Last month the United Nations’ Intergovernmental Panel on Climate Change (IPCC) released its Synthesis Report of the Sixth Assessment Report.
It showed global temperatures are now 1.1℃ above pre-industrial levels. This warming has driven widespread and rapid global changes, including more frequent and intense weather extremes that are now impacting people and ecosystems all over the world.
But when an extreme weather event hits, how certain can we be that it was made more likely by climate change? How do we know it wasn’t just a rare, naturally-occuring event that might have happened anyway?
Fear & Wonder is a new podcast from The Conversation that takes you inside the UN’s era-defining climate report via the hearts and minds of the scientists who wrote it.
The show is hosted by Dr Joëlle Gergis – a climate scientist and IPCC lead author – and award-winning journalist Michael Green.
In this episode, we’re delving into one of the major shifts in the public communication of climate change – the attribution of extreme weather events to climate change.
Although in the past we knew climate change was making extreme weather more likely, advances in climate modelling now allow scientists to pinpoint the influence of natural and human-caused factors on individual weather extremes.
We speak to climatologist Dr Friederike Otto about a rapid attribution study of a heatwave in Toulouse, France, as it unfolded in 2019. We also hear from climatologist Professor David Karoly to help us understand how climate models actually work, while Professor Tannecia Stephenson explains how global models are then used to develop regional climate change projections over the Caribbean island of Jamaica.
To listen and subscribe, click here, or click the icon for your favourite podcast app in the graphic above.


NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026




